Gary M. Stuhlmiller, PhD

Gary M. Stuhlmiller, PhD, serves as a technical director in the division of DNA identity testing at Labcorp. He joined Labcorp following 11 years on the faculty in the Department of Surgery at Duke University Medical Center, where he was technical director of the Melanoma Immunobiology Laboratory. Dr. Stuhlmiller holds a BS in Microbiology from Cornell University and a PhD in Immunology from Duke University. Dr.

Minghui Li, PhD, MLS (ASCP), S(ACHI)

Dr. Minghui Li earned his PhD in cellular and molecular biology from the University of Nevada, Reno, and his master’s degree in clinical laboratory science from Augusta University, Augusta, GA. Dr Li joined the DNA Identification laboratory after completing his HLA lab director- in-training at Virginia Commonwealth University’s HLA laboratory. His current responsibilities include human leukocyte antigen (HLA) testing for disease associations, pharmacogenomics and histocompatibility support for transplant centers and bone marrow registries. Dr.

Vera C Lattier, PhD

Dr. Vera Lattier received her PhD in molecular and cellular biology from Oregon State University, Corvallis, and her master’s degree in pathology from National Taiwan University, Taipei, Taiwan. She completed post-doctoral training at the National Cancer Institute, National Institute of Health, Bethesda, MD. Before joining Labcorp, she worked as a research and development scientist in drug discovery and assay development. She has discovered several genetic biomarkers associated to disease prognosis and published numerous scientific articles in international journals.

Megan Shaffer, PhD, S(ACHI)

Dr. Megan Shaffer completed her PhD in microbiology and immunology at Louisiana State University Health Sciences Center, Shreveport, and continued post-doctoral training at Louisiana State University Health Sciences Center, New Orleans. Dr. Shaffer holds a certificate of qualification from the New York State Department of Health to act as a laboratory director in the categories of histocompatibility, transplant monitoring, forensic identity and parentage/identity testing. She is board certified as an associate of the American College of Histocompatibility and Immunogenetics (ACHI).

Ruth P Koester, PhD, F(ACHI)

Dr. Ruth Koester is a fellow of the American College of Histocompatibility and Immunogenetics (ACHI), and she is a member of American Society for Histocompatibility and Immunogenetics (ASHI), the European Federation for Immunogenetics (EFI) and the World Marrow Donor Association (WMDA). She earned a BS from Cornell University and a PhD in Genetics from North Carolina State University.

<span>Why a biometric screening is essential</span>
August 30, 2023

Why a biometric screening is essential

What is a biometric screening?The Centers for Disease Control and Prevention (CDC) defines biometric screening as “themeasurement of physical characteristics such as height, weight, body mass index (BMI), bloodpressure, blood cholesterol and blood glucose that can be taken at the work site and used as part of a workplace health assessment.” This information becomes the baseline to monitor and evaluate changes in an employee’s health each year. 

Kathleen Bailey, MS, NP, PhD

As a Nurse Practitioner, Kathleen provided direct patient care for 5 years and also participated in clinical research and as a Director of medical staff in HIV and infectious disease private practice settings.